Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Citations Over TimeTop 1% of 2011 papers
Abstract
Gold(I) complexes with a 1,3-diethylbenzimidazol-2-ylidene N-heterocyclic carbene (NHC) ligand of the type NHC-Au-L (L=-Cl, -NHC, or -PPh3) were comparatively evaluated as thioredoxin reductase (TrxR) inhibitors and antimitochondrial anticancer agents. Different effects were noted in various biochemical assays (e.g., inhibition of TrxR, cellular and mitochondrial uptake, or effects on mitochondrial membrane potential), and this was related to properties of the complexes such as bond dissociation energies and overall charge. Remarkable antiproliferative effects, a strong induction of apoptosis, and enhancement of reactive oxygen species (ROS) formation as well as other effects on tumor cell metabolism confirmed the promising potential of the complexes as novel anticancer chemotherapeutics.
Related Papers
- → Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs(2009)580 cited
- Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.(1997)
- → The Thioredoxin System: A Promising Target for Cancer Drug Development(2020)97 cited
- → The logic of kinetic regulation in the thioredoxin system(2011)43 cited
- Selenium and the thioredoxin redox system: effects on cell growth and death.(1997)